UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044944
Receipt number R000051339
Scientific Title An observational study of changes in exercise capacity associated with long hospitalization in patients with lung, esophageal, and head and neck cancer undergoing radiotherapy and chemoradiotherapy -Pilot study-
Date of disclosure of the study information 2021/07/23
Last modified on 2022/12/28 08:19:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An observational study of changes in exercise capacity associated with long hospitalization in patients with lung, esophageal, and head and neck cancer undergoing radiotherapy and chemoradiotherapy -Pilot study-

Acronym

An observational study of changes in exercise capacity in patients undergoing hospitalized RT and CRT

Scientific Title

An observational study of changes in exercise capacity associated with long hospitalization in patients with lung, esophageal, and head and neck cancer undergoing radiotherapy and chemoradiotherapy -Pilot study-

Scientific Title:Acronym

An observational study of changes in exercise capacity in patients undergoing hospitalized RT and CRT

Region

Japan


Condition

Condition

Non-small cell lung cancer, esophageal cancer, head and neck cancer

Classification by specialty

Medicine in general Radiology Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the proportion and characteristics of patients who decreased exercise capacity beyond minimal clinically important difference, in patients with lung, esophageal, and head and neck cancer who are scheduled for long hospitalization for radiotherapy and chemoradiotherapy.

Basic objectives2

Others

Basic objectives -Others

To explore the effects of long hospitalization treatment on motor function and characteristics of these changes, and to consider the appropriate timing and content of rehabilitation.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Proportion and characteristics of patients who decreased exercise capacity beyond minimal clinically important difference (a decrease of more than -40 m in the 6-minute walk test) between the start of irradiation and 4-8 weeks after the start of irradiation.

Key secondary outcomes

Relationship between exercise capacity and physical activity, sarcopenia, fatigue, cachexia, and quality of life, and these changes.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Non-small cell lung cancer (n=20)
Esophageal cancer (n=20)
Head and neck cancer (n=20)

1) they are scheduled for radical or semi-radical RT/CRT
2) They are scheduled to be hospitalized for at least 3 weeks from the start of irradiation.
3) Having written informed consent
4) Able to read and write Japanese

Key exclusion criteria

1) They are hospitalized only during chemotherapy
2) Stereotactic body radiation therapy is scheduled.
3) RT/CRT as adjuvant therapy before and after surgery
4) Diagnosis of unstable angina or myocardial infarction within 1 month prior to enrollment
5) Having bone metastases with limited exercise by doctor
6) Having psychosis or neurological symptoms that make it difficult to administer the questionnaire accurately
7) Determined by the doctor to be ineligible for enrollment in this study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Fuseya

Organization

Shizuoka Cancer Center

Division name

Division of Rehabilitation Medicine

Zip code

411-8777

Address

1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan

TEL

055-989-5222

Email

h.fuseya@scchr.jp


Public contact

Name of contact person

1st name Midori
Middle name
Last name Unno

Organization

Shizuoka Cancer Center

Division name

Division of Rehabilitation Medicine

Zip code

411-8777

Address

1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan

TEL

055-989-5222

Homepage URL


Email

mi.kitagawa@scchr.jp


Sponsor or person

Institute

Shizuoka Cancer Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shizuoka Cancer Center

Address

1007 Shimnagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan

Tel

055-989-5222

Email

tansaku_office@scchr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 06 Month 28 Day

Date of IRB

2021 Year 06 Month 28 Day

Anticipated trial start date

2021 Year 07 Month 26 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 07 Month 23 Day

Last modified on

2022 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051339


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name